Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
20,248.28
18,822.82
17,755.59
12,401.68
6,306.60
4,517.17
3,001.94
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
20,248.28
18,822.82
17,755.59
12,401.68
6,306.60
4,517.17
3,001.94
Raw Material Cost
11,953.08
11,278.00
9,936.38
6,581.84
3,460.32
2,636.19
1,796.46
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
7,216.20
6,888.05
6,496.27
5,191.96
2,443.68
1,046.39
736.93
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
170.86
175.13
74.87
47.23
48.02
22.23
0.00
Selling and Distribution Expenses
2,492.52
2,330.81
1,966.46
1,394.73
816.83
511.63
386.24
Other Expenses
-655.61
-619.48
-577.71
-463.47
-215.04
-77.42
-53.64
Total Expenditure (Excl Depreciation)
15,276.59
14,477.14
12,696.88
8,581.08
4,618.45
3,442.25
2,383.21
Operating Profit (PBDIT) excl Other Income
4971.7
4345.7
5058.7
3820.6
1688.1
1074.8999999999999
618.6999999999999
Other Income
540.18
426.21
836.24
310.30
178.03
224.37
241.84
Operating Profit (PBDIT)
7,310.82
6,303.04
7,107.82
4,978.28
2,381.99
1,550.30
1,028.21
Interest
170.86
175.13
74.87
47.23
48.02
22.23
0.00
Exceptional Items
-99.44
15.29
410.35
728.88
387.80
3.99
13.23
Gross Profit (PBDT)
8,295.20
7,544.82
7,819.21
5,819.84
2,846.28
1,880.97
1,205.48
Depreciation
1,798.95
1,531.15
1,212.87
847.38
515.82
251.01
167.64
Profit Before Tax
5,241.57
4,612.04
6,230.44
4,812.55
2,205.95
1,281.04
873.80
Tax
963.90
666.51
939.45
583.97
306.84
131.87
127.04
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3,638.74
3,756.69
5,140.25
4,083.83
1,897.79
1,149.57
746.91
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3,638.74
3,756.69
5,140.25
4,083.83
1,897.79
1,149.57
746.91
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
638.92
188.84
150.73
144.75
4.28
-3.93
-0.15
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
4,277.67
3,945.53
5,290.99
4,228.58
1,902.07
1,145.64
746.76
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
44,504.51
44,405.30
39,349.12
39,485.29
24,382.03
14,300.53
9,115.74
Earnings per share (EPS)
0.85
0.85
1.17
0.92
0.45
0.29
0.19
Diluted Earnings per share
0.85
0.85
1.17
0.92
0.45
0.29
0.19
Operating Profit Margin (Excl OI)
24.55%
23.09%
28.49%
30.81%
26.77%
23.8%
20.61%
Gross Profit Margin
34.77%
32.64%
41.92%
45.64%
43.16%
33.92%
34.69%
PAT Margin
17.97%
19.96%
28.95%
32.93%
30.09%
25.45%
24.88%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 7.57% vs 6.01% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 8.42% vs -25.43% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 15.21% vs -6.30% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -2.40% vs 133.78% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Wuxi Biologics (Cayman), Inc. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
20,248.28
31,452.52
-11,204.24
-35.62%
Other Operating Income
0.00
0.00
0.00
Total Operating income
20,248.28
31,452.52
-11,204.24
-35.62%
Raw Material Cost
11,953.08
9,444.18
2,508.90
26.57%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
7,216.20
4,744.41
2,471.79
52.10%
Power Cost
0
0
0.00
Manufacturing Expenses
170.86
47.35
123.51
260.84%
Selling and Distribution Expenses
2,492.52
10,576.50
-8,083.98
-76.43%
Other Expenses
-655.61
83.61
-739.22
-884.13%
Total Expenditure (Excl Depreciation)
15,276.59
25,648.52
-10,371.93
-40.44%
Operating Profit (PBDIT) excl Other Income
4,971.69
5,804.01
-832.32
-14.34%
Other Income
540.18
502.20
37.98
7.56%
Operating Profit (PBDIT)
7,310.82
7,754.89
-444.07
-5.73%
Interest
170.86
47.35
123.51
260.84%
Exceptional Items
-99.44
-113.26
13.82
12.20%
Gross Profit (PBDT)
8,295.20
22,008.35
-13,713.15
-62.31%
Depreciation
1,798.95
1,448.68
350.27
24.18%
Profit Before Tax
5,241.57
6,145.60
-904.03
-14.71%
Tax
963.90
1,344.33
-380.43
-28.30%
Provisions and contingencies
0
0
0.00
Profit After Tax
3,638.74
4,692.56
-1,053.82
-22.46%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
3,638.74
4,692.56
-1,053.82
-22.46%
Share in Profit of Associates
0
0
0.00
Minority Interest
638.92
11.70
627.22
5,360.85%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
4,277.67
4,704.26
-426.59
-9.07%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
44,504.51
34,336.48
10,168.03
29.61%
Earnings per share (EPS)
0.85
0.40
0.45
112.50%
Diluted Earnings per share
0.85
0.40
0.45
112.50%
Operating Profit Margin (Excl OI)
24.55%
18.45%
0.00
6.10%
Gross Profit Margin
34.77%
24.15%
0.00
10.62%
PAT Margin
17.97%
14.92%
0.00
3.05%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 2,024.83 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 7.57% vs 6.01% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 427.77 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 8.42% vs -25.43% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 677.06 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 15.21% vs -6.30% in Dec 2023
Annual - Interest
Interest 17.09 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -2.40% vs 133.78% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.55%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






